Bridgewater Associates’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-35,356
| Closed | -$1.82M | – | 979 |
|
|
2022
Q2 | $1.82M | Buy |
35,356
+31,335
| +779% | +$1.61M | 0.01% | 698 |
|
|
2022
Q1 | $296K | Buy |
4,021
+1,581
| +65% | +$116K | ﹤0.01% | 938 |
|
|
2021
Q4 | $349K | Buy |
2,440
+1,303
| +115% | +$186K | ﹤0.01% | 681 |
|
|
2021
Q3 | $236K | Buy |
+1,137
| New | +$236K | ﹤0.01% | 658 |
|